Amundi’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
21,203
-13,195
-38% -$642K ﹤0.01% 1318
2026
Q1
$1.48M Sell
34,398
-121,348
-78% -$5.22M ﹤0.01% 1174
2025
Q4
$6.83M Buy
155,746
+142,244
+1,054% +$5.88M ﹤0.01% 984
2025
Q3
$540K Hold
13,502
﹤0.01% 1301
2025
Q2
$598K Sell
13,502
-2,799
-17% -$112K ﹤0.01% 1328
2025
Q1
$598K Sell
16,301
-7,504
-32% -$267K ﹤0.01% 1452
2024
Q4
$821K Sell
23,805
-14,170
-37% -$460K ﹤0.01% 1445
2024
Q3
$964K Buy
37,975
+12,942
+52% +$322K ﹤0.01% 1295
2024
Q2
$550K Sell
25,033
-6,281
-20% -$139K ﹤0.01% 1331
2024
Q1
$704K Sell
31,314
-152,248
-83% -$3.38M ﹤0.01% 1353
2023
Q4
$4.27M Buy
183,562
+45,100
+33% +$981K ﹤0.01% 1015
2023
Q3
$2.96M Buy
138,462
+42,411
+44% +$887K ﹤0.01% 1084
2023
Q2
$1.84M Buy
96,051
+84,974
+767% +$1.64M ﹤0.01% 1174
2023
Q1
$220K Sell
11,077
-112,923
-91% -$1.97M ﹤0.01% 1545
2022
Q4
$2.08M Buy
+124,000
New +$2.02M ﹤0.01% 1184
2022
Q1
Sell
-19,615
Closed -$349K 1663
2021
Q4
$349K Hold
19,615
﹤0.01% 1434
2021
Q3
$415K Buy
+19,615
New +$364K ﹤0.01% 1368

Other funds holding EXEL

Amundi's EXEL Position: Q2 2026 in Review

Amundi reduced its Exelixis (EXEL) stake by 38% in Q2 2026, selling an estimated $642K and leaving 21,203 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

Amundi first reported a position in EXEL in Q3 2021 and has held it in 17 quarters since. The position peaked at $6.83M in Q4 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Amundi held 21,203 shares of Exelixis worth $1.15M as of Q2 2026.
  • Amundi sold 13,195 Exelixis shares in Q2 2026, an estimated $642K.
  • Exelixis made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1318 holding.
  • Amundi first reported a position in Exelixis in Q3 2021 and has held it in 17 quarters since.
  • Amundi's Exelixis position peaked at $6.83M in Q4 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.